Medicine & Health

Jeffrey I. Gordon, MD, explores the “vast, mysterious world” of the microbiome to find solutions to promote healthy growth in malnourished children. In recognition of his groundbreaking work, Gordon received the 2022 Dr. Paul Janssen Award for Biomedical Research.

Medicaid expansion may improve outcomes for children with cancer, finds a new analysis from the Brown School and the School of Medicine. Researchers found there was a 1.5% increase in overall survival after 2014 in states that expanded access to Medicaid compared with states that did not.

In the seminar “Cognitive Illusions,” students in psychological and brain sciences examine the causes and consequences of errors in thinking.

Results of a major clinical trial in Africa led by Mark Manary, MD, at Washington University School of Medicine, have prompted a change in global guidelines for therapeutic food.

Researchers at Washington University School of Medicine have discovered that the difference between cancer patients who do and do not respond to immunotherapy may have to do with a particular immune cell. The findings could extend the lifesaving benefits of immunotherapy to more patients.

Africans have made great strides fighting the legacy of colonialism while contending with the ongoing plunder of their natural resources and geopolitical battles for influence on the continent. Despite this progress, difficulties remain, including poverty, environmental challenges and public health issues.

On Feb. 25, the Medical Humanities Program in Arts & Sciences will present the “Forum on Medicine, Race and Ethnicity in St. Louis, Past to Future.” The all-day gathering will feature dozens of speakers and panelists exploring how specific local histories impact the region’s diverse communities.

Software developed at Washington University School of Medicine can predict what happens to complex gene networks when individual genes are disrupted in specific ways.

Researchers at Washington University School of Medicine have discovered that the fluid around the brain flows to areas critical for normal brain development and function, suggesting that disruptions to its circulation may play an underrecognized role in neurodevelopmental disorders.

A $15 million commitment from Washington University benefactors Philip and Sima Needleman will enable the university to leverage its expertise in biomedical discovery to boost drug development via the Needleman Program for Innovation and Commercialization.